Expression of PD-L1 on CD4+CD25+Foxp3+ Regulatory T Cells of Patients with Chronic HBV Infection and Its Correlation with Clinical Parameters

Viral Immunology

Volumn 28, Issue 8, 2015, Pages 418-424

  Feng, Chao ^a   Cao, Li Juan ^a   Song, Hua Feng ^a,b   Xu, Ping ^b   Chen, Hui ^b   Xu, Jun Chi ^b   Zhu, Xiao Yan ^b   Zhang, Xue Guang ^a,b   Wang, Xue Feng ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROGRAMMED DEATH 1 LIGAND 1; TRANSCRIPTION FACTOR FOXP3; CD274 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FREQUENCY; HUMAN; IMMUNE RESPONSE; LIVER INJURY; MALE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; BLOOD; CHEMISTRY; HEPATITIS B; IMMUNOLOGY; PATHOLOGY;

ADULT; ALANINE TRANSAMINASE; ANTIGENS, CD274; ANTIGENS, CD4; ASPARTATE AMINOTRANSFERASES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 84942888007     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2015.0062     Document Type: Article

References (39)

1. Alatrakchi N, and Koziel M. Regulatory T cells and viral liver disease. J Viral Hepat 2009;16:223-229
2. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682-687
3. Barbi J, Pardoll D, and Pan F. Treg functional stability and its responsiveness to the microenvironment. Immunol Rev 2014;259:115-139
4. Bengsch B, Martin B, and Thimme R. Restoration of HBVspecific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol 2014;61:1212-1219
5. Bettini M, and Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009;21:612-618
6. Cai G, Nie X, Li L, et al. B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function. J Gastroenterol 2013;48:1362-1372
7. Chen JH, Perry CJ, Tsui YC, et al. Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat Med 2015;21:327-334
8. Cretney E, Kallies A, and Nutt SL. Differentiation and function of Foxp3(+) effector regulatory T cells. Trends Immunol 2013;34:74-80
9. Dolina JS, Braciale TJ, and Hahn YS. Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology 2014;59:1351-1365
10. Ferris RL, Lu B, and Kane LP. Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion. J Immunol 2014;193:1525-1530
11. Fourcade J, Sun Z, Pagliano O, et al. CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res 2012;72:887-896
12. Franzese O, Kennedy PT, Gehring AJ, et al. Modulation of the CD8+-T-cell response by CD4+CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005;79:3322-3328
13. Fu J, Xu D, Liu Z, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007;132: 2328-2339
14. Geng S, Zhong Y, Wang S, et al. Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells. PloS One 2012;7:e33015
15. Gotot J, Gottschalk C, Leopold S, et al. Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo. Proc Natl Acad Sci U S A 2012;109:10468-10473
16. Haymaker C, Wu R, Bernatchez C, et al. PD-1 and BTLA and CD8(+) T-cell ''exhaustion'' in cancer: ''exercising'' an alternative viewpoint. Oncoimmunology 2012;1:735-738
17. Huang YH, Zhu C, Kondo Y, et al. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature 2015; 517:386-390
18. Kaufmann DE, and Walker BD. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 2009;182:5891-5897
19. Keir ME, Butte MJ, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity. Ann Rev Immunol 2008;26: 677-704
20. Kitazawa Y, Fujino M, Wang Q, et al. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation 2007;83:774-782
21. Lai CL, and Yuen MF. Prevention of hepatitis B virusrelated hepatocellular carcinoma with antiviral therapy. Hepatology 2013;57:399-408
22. Liu J, Zhang E, Ma Z, et al. Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection. PLoS Pathog 2014;10:e1003856
23. Maier H, Isogawa M, Freeman GJ, et al. PD-1:PD-L1 interactions contribute to the functional suppression of virusspecific CD8+ T lymphocytes in the liver. J Immunol 2007;178:2714-2720
24. Nan XP, Zhang Y,Yu HT, et al. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection. Viral Immunol 2010;23:63-70
25. Nebbia G, Peppa D, Schurich A, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PloS One 2012;7:e47648
26. Papatheodoridis GV, Chan HL, Hansen BE, et al. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol 2015;62:956-967
27. Pauken KE, and Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol 2015;36: 265-276
28. Peng G, Li S, Wu W, et al. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008;45:963-970
29. Powles T, Eder JP, Fine GD, et al. MPDL3280A (anti-PDL1) treatment leads to clinical activity in metastatic bladder cancer. Nature 2014;515:558-562
30. Ringelhan M, O'Connor T, Protzer U, et al. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. J Pathol 2015;235:355-367
31. Schurich A, Khanna P, Lopes AR, et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011;53:1494-1503
32. Stoop JN, van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005;41:771-778
33. Tao R, Wang L, Murphy KM, et al. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells. J Immunol 2008;180:6649-6655
34. Tumeh PC, Harview CL, Yearley JH, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 2014;515:568-571
35. Wang W, Lau R, Yu D, et al. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol 2009;21:1065-1077
36. Xibing G, Xiaojuan Y, and Juanhua W. PD-1 expression on CTL may be related to more severe liver damage in CHB patients with HBV genotype C than in those with genotype B infection. J Viral Hepat 2013;20:e1-2
37. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006;177:739-747
38. Xu P, Chen YJ, Chen H, et al. The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics. Gut Liver 2014;8:186-195
39. Yang P, Li QJ, Feng Y, et al. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 2012;22:291-303